Clinical

Dataset Information

Immunotherapy Combined With Y-90 and SBRT for Colorectal Liver Metastases


ABSTRACT: This study is evaluating the combination of Y-90 radioembolization followed by SBRT with the immunotherapy drugs, durvalumab and tremelimumab, to improve disease control of liver metastases for patients with microsatellite stable colorectal cancer.

DISEASE(S): Neoplasm Metastasis,Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2294253 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR